HopeStage
Back to all studies
CompletedNCT04228094

TDApp1: Medication Recommendations for ADHD

About this titleRead the official source — NCT04228094
Observational studyAges 6–65Spain
The study in practice

Understand this study

Who was this study for?

This study was for people with ADHD. Listed age limits: 6 years to 65 years. Other eligibility criteria applied.

Listed locations
GironaSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: August 10, 2020
Recruitment status
Completed
Enrollment listed in the registry
33
Sponsor
Universitat de Girona
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
OTHER
Study phase
Not clearly listed
Locations
Spain
Age range
From 6 Years to 65 Years
Official registry ID
NCT04228094
Official title
Show the full official title

Development and Assesment of TDApp1 an eHelath Tool to Make Participatory, Patient-centred and Automated Therapeutic Recommendations for Patients With Attention Deficit Hyperactivity Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Girona

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Universitat de Girona.

Who was this study for?

This study was for people with ADHD. Listed age limits: 6 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies